The estimated Net Worth of Jane Emerson is at least $22.1 mil dollars as of 5 October 2018. Jane Emerson owns over 25,000 units of Biomerica stock worth over $22,081 and over the last 10 years he sold BMRA stock worth over $0. In addition, he makes $0 as Independent Director at Biomerica.
Sign up
Jane Emerson BMRA stock SEC Form 4 insiders trading
Jane has made over 4 trades of the Biomerica stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of BMRA stock worth $18,750 on 5 October 2018.
The largest trade he's ever made was exercising 25,000 units of Biomerica stock on 5 October 2018 worth over $18,750. On average, Jane trades about 5,462 units every 71 days since 2015. As of 5 October 2018 he still owns at least 71,000 units of Biomerica stock.
You can see the complete history of Jane Emerson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jane Emerson biography
Dr. Jane F. Emerson M.D. Ph.D. serves as Independent Director of the Company. Since July 1, 2009, Dr. Emerson has served as Vice Chair for Clinical Programs and Chief of Clinical Pathology at the University of Southern California Keck School of Medicine, Los Angeles, California. From 1994 to 2009, Dr. Emerson was on the faculty of the University of California, Irvine School of Medicines where she served as Chief of Clinical Pathology and from 2000 to 2009, also served as the Vice Chair for Clinical Programs, Department of Pathology and Laboratory Medicine.
How old is Jane Emerson?
Jane Emerson is 66, he's been the Independent Director of Biomerica since 2007. There are 2 older and 7 younger executives at Biomerica. The oldest executive at Biomerica Inc. is Francis Cano, 76, who is the Independent Director.
Insiders trading at Biomerica
Over the last 12 years, insiders at Biomerica have traded over $80,900 worth of Biomerica stock and bought 151,277 units worth $334,788 . The most active insiders traders include Mark A Sirgo, David Moatazedi, eJohn P. Kenny. On average, Biomerica executives and independent directors trade stock every 61 days with the average trade being worth of $3,349. The most recent stock trade was executed by Zackary S. Irani on 25 May 2023, trading 700 units of BMRA stock currently worth $1,113.
What does Biomerica do?
biomerica, inc. (www.biomerica.com) is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. the company’s products are designed to enhance health and well-being, while reducing total healthcare costs. biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing. the biomerica infoods® ibs product identifies patient specific foods that when removed may alleviate an individual's ibs symptoms. this patent pending diagnostic guided therapy is designed to allow for a patient specific guided dietary regimen to improve irritable bowel syndrome (ibs) outcomes. the point-of-care product is being developed to allow physicians to perform the test in-office using a finger stick blood sample while a clinical lab version of the product will be the first for wh
What does Biomerica's logo look like?
Complete history of Jane Emerson stock trades at Biomerica
Biomerica executives and stock owners
Biomerica executives and other stock owners filed with the SEC include:
-
Zackary Irani,
Chairman of the Board, Chief Executive Officer -
Steven Sloan,
CFO & Treasurer -
Janet Moore,
Treasurer, Secretary, Director -
Zackary S. Irani,
Chairman & CEO -
Allen C. Barbieri,
Exec. Vice-Chairman & Corp. Sec. -
Mark Sirgo,
Independent Director -
Jane Emerson,
Independent Director -
Catherine Coste,
Independent Director -
Francis Cano,
Independent Director -
Allen Barbieri,
Lead Independent Executive Vice Chairman of the Board -
Steven Sloan,
Chief Financial Officer -
Robert W. Carlson,
Chief Commercial Officer -
Hans Boehringer,
Sr. VP of POC R&D -
Lucy Liu Ph.D.,
Director of Manufacturing & Technical Operations -
David Moatazedi,
Director -
Francis E Capitanio,
President -
Janet Trust Dtd 8/21/98 Moore,
-
John P. Kenny,
Director -
Gary Lu,
Chief Financial Officer